Samina Khan Reata Pharmaceuticals Inc (RETA) insider trading activity

Samina Khan is SVP, Chief Medical Officer of REATA PHARMACEUTICALS INC. Currently has a direct ownership of 39,491 shares of RETA, which is worth approximately $0. The most recent transaction as insider was on May 16, 2023, when has been sold 352 shares (Class A Common Stock) at a price of $81.37 per share, resulting in proceeds of $28,642. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.5K

0% 3M change

0% 12M change

Total Value Held $0

Samina Khan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2023	SELL Open market or private sale	$28,642 $81.37 p/Share	352 Reduced 0.88%	39,491 Class A Common Stock
May 15 2023	SELL Open market or private sale	$24,572 $85.32 p/Share	288 Reduced 0.72%	39,843 Class A Common Stock
Mar 07 2023	SELL Open market or private sale	$330,585 $83.46 p/Share	3,961 Reduced 8.98%	40,131 Class A Common Stock
Mar 03 2023	SELL Open market or private sale	$245,743 $87.36 p/Share	2,813 Reduced 6.0%	44,092 Class A Common Stock
Mar 02 2023	SELL Open market or private sale	$2,117,500 $84.7 p/Share	25,000 Reduced 34.77%	46,905 Class A Common Stock
Mar 02 2023	BUY Exercise of conversion of derivative security	$683,000 $27.32 p/Share	25,000 Added 25.8%	71,905 Class A Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	11,756 Added 20.04%	46,905 Class A Common Stock

Samina Khan

SVP, Chief Medical Officer

Plano, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RETA shares.

Notify only if

Value

Insider Trading

Get notified when an Reata Pharmaceuticals Inc insider buys or sells RETA shares.

Notify only if

Operation

Value

Type

News

Receive news related to REATA PHARMACEUTICALS INC

Track Activities on RETA

Account